Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …

Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and
vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) …

Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC/EACTS en la toma de decisiones clínicas en su ejercicio diario, así como en …

Aims Catheter ablation is the most efficacious rhythm control therapy in atrial fibrillation (AF)
patients. There is growing evidence that catheter ablation procedures are best performed …

Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …

Background Stroke is the major cause of morbidity and mortality related to atrial fibrillation
(AF). Catheter ablation for AF is effective in reducing AF burden, but its impact on long-term …

Aims Although a recent expert consensus statement has recommended periprocedural
uninterrupted (UI) non-vitamin K antagonist oral anticoagulants (NOACs) during catheter …